37 studies found for:    Open Studies | "Vitamin K"
Show Display Options
Rank Status Study
21 Recruiting Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification
Conditions: Atrial Fibrillation or Pulmonary Embolism;   Need of Long Term Oral Anticoagulation Therapy (OAT);   Existent Coronary or Valvular Calcification, or Both and Agatston Score > 50 in at Least One Location
Intervention: Drug: Rivaroxaban or Marcumar
22 Unknown  International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage
Condition: Intracranial Hemorrhages
Intervention: Drug: Prothrombin complex concentrate (PCC); fresh frozen plasma (FFP)
23 Recruiting Use of Phytonadione to Reduce International Normalized Ratio (INR) Variability in Patients on Long-term Warfarin Therapy
Condition: Coagulation Delay
Interventions: Dietary Supplement: phytonadione;   Drug: none-control group
24 Recruiting Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation
Conditions: Permanent Atrial Fibrillation;   Venous Thrombosis;   Pulmonary Embolism;   Anticoagulating Treatment on a Duration at Least 12-month-old Superior
Interventions: Drug: Rivaroxaban;   Drug: Fluindione;   Drug: Warfarin
25 Recruiting Nutritional Status of Patients Victims of Haemorragic Accidents With Antivitamins K
Conditions: Hemorrhagic Accident;   Iatrogeny;   Denutrition
Intervention:
26 Recruiting Optimal Duration of Anticoagulation in Deep Venous Thrombosis
Conditions: Deep Venous Thrombosis of the Lower Extremities;   Symptomatic Recurrent Venous Thromboembolism
Intervention: Drug: Sodium warfarin
27 Recruiting Edoxaban vs. Warfarin in Subjects Undergoing Cardioversion of Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: edoxaban;   Drug: Enoxaparin;   Drug: Warfarin
28 Recruiting Open Label Study Comparing Efficacy and Safety of Dabigatran Etexilate to Standard of Care in Paediatric Patients With Venous Thromboembolism (VTE)
Condition: Venous Thromboembolism
Interventions: Drug: dabigatran etexilate;   Drug: standard of care
29 Recruiting BAY 59-7939 (Xarelto, SPAF), Non Interventional Studies
Condition: Atrial Fibrillation
Interventions: Drug: Phenprocoumon (Marcumar);   Drug: Rivaroxaban (Xarelto, BAY-59 7939)
30 Not yet recruiting A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI
Condition: Rash Due to Epidermal Growth Factor Receptor Inhibitors
Interventions: Drug: RECONVAL CREAM;   Drug: PLACEBO
31 Recruiting Patent Foramen Ovale Closure or Anticoagulants Versus Antiplatelet Therapy to Prevent Stroke Recurrence
Conditions: Ischemic Stroke;   Patent Foramen Ovale;   Atrial Septal Aneurysm;   Migraine
Interventions: Drug: aspirin;   Drug: Antivitamins K;   Device: Devices for PFO closure
32 Recruiting Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism
Condition: Venous Thromboembolism
Intervention:
33 Recruiting Xarelto Regulatory Post-Marketing Surveillance
Condition: Venous Thromboembolism
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Pharmacologic agents (e.g. LMWH/VKA/Fondaparinux/Aspirin and etc.)
34 Recruiting Left Atrial Appendage Occlusion vs. Usual Care in Patients With Atrial Fibrillation and Severe Chronic Kidney Disease
Conditions: Blood Coagulation Disorders;   Atrial Fibrillation;   Thrombosis of Left Atrial Appendage;   Chronic Kidney Disease Stage 4;   Chronic Kidney Disease Stage 5
Intervention: Device: Left atrial appendage occlusion
35 Recruiting LV Thrombus After Acute AMI: A Randomized Controlled Trial
Condition: Ventricular Thrombosis Mural Following Myocardial Infarction
Intervention: Drug: Absence of Acenocoumarol
36 Recruiting DUTCH CAVA-trial: CAtheter Versus Anticoagulation Alone for Acute Primary (Ilio)Femoral DVT.
Condition: Acute Thrombosis of Deep Veins of Proximal Lower Extremity
Intervention: Device: Ekos endowave system thrombolysis
37 Unknown  Non Invasive Measurement of Coagulation in Term and Preterm Neonates
Condition: Blood Coagulation Tests
Intervention: Device: The Thrombo-Monitor (ThM)

Show previous page of results Previous Page (1-20) Studies Shown (21-37) Next Page
Indicates status has not been verified in more than two years